Clinical Trial

Shockwave™Peripheral Intravascular Lithotripsy Balloon for Advanced Endovascular Aortic Repair

Study acronym: TEVAR
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 23, 2025 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Shockwave TEVAR is a nonrandomized, prospective, international, multi-center, PMCF, obervational study. The aim of this study is to evaluate the outcomes of the Shockwave™ Peripheral Intravascular Lithotripsy Balloon (Shockwave Medical Inc.) in the routine treatment of hostile iliac accesses during TEVAR and F/BEVAR.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-03-20; most recent amendment 2025-05-19.
Status change: Not Yet Recruiting → Recruiting 2025-05-19
Trial Details
NCT Number NCT06332911
Lead Sponsor Rede Optimus Hospitalar SA
Collaborators: Shockwave Medical, Inc.
Conditions Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture, Abdominal Aortic Aneurysm Without Rupture, Thoracic Aortic Aneurysm Without Rupture
Enrollment 30 participants
Start Date 2025-05-19
Primary Completion 2026-05-30 (estimated)
Study Completion 2027-05-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-23